FDA GUIDANCE SNAPSHOT:
Conducting Clinical Trials With Decentralized Elements. Guidance for Industry, Investigators, and Other Interested Parties
This guidance provides FDA’s recommendations for sponsors, investigators, and other interested parties regarding the implementation of decentralized elements in clinical trials.
OCTOBER 2026